Pneumovax 23 works by exposing your immune system to pieces of 23 types of pneumococcal bacteria, training your body to recognize and fight these bacteria if you encounter them in the future.

What Pneumovax 23 Does in Your Body

Think of Pneumovax 23 like a "wanted poster" for your immune system. The vaccine contains tiny sugar molecules (called polysaccharides) taken from the outer coating of 23 different types of Streptococcus pneumoniae bacteria. These polysaccharides are harmless on their own — they can't cause infection — but they look enough like the real bacteria to trigger your immune system into action.

Here's what happens step by step:

1. You get the shot. The 23 polysaccharide antigens enter your body through the injection.
2. Your immune system spots them. Your B cells (a type of white blood cell) recognize these foreign sugar molecules as potential threats.
3. Antibodies are produced. Your B cells start making antibodies — specialized proteins designed to latch onto each specific type of pneumococcal bacteria.
4. Your body builds a defense. These antibodies circulate in your blood. If you're later exposed to real pneumococcal bacteria, the antibodies recognize the bacteria's sugar coating and flag them for destruction.

It's like your immune system studying mugshots. It won't chase a criminal it's never seen before, but show it the photos ahead of time, and it can spring into action the moment a match shows up.

A Technical Detail: T-Cell Independent Response

Here's something that makes Pneumovax 23 different from some other vaccines: it triggers what scientists call a T-cell independent immune response. In plain terms, this means the vaccine activates your B cells directly, without needing help from another type of immune cell called T cells.

Why does this matter? Two reasons:

• It works well in adults whose immune systems are mature enough to respond to polysaccharide antigens.
• It doesn't work well in children under 2, because young children's immune systems need T-cell help to respond to these types of antigens. That's why Pneumovax 23 isn't approved for kids under 2.

This T-cell independent response also means Pneumovax 23 doesn't create strong immune memory the way conjugate vaccines do (more on that below). Your body makes antibodies, but they may gradually decrease over time.

How Long Does Pneumovax 23 Take to Work?

After vaccination, your immune system needs time to build up antibodies. Most people develop protective antibody levels within 2 to 3 weeks after receiving the shot. This is why doctors may recommend getting vaccinated before the respiratory illness season ramps up, rather than waiting until you're already at risk.

The vaccine doesn't provide instant protection — so if you're exposed to pneumococcal bacteria in the first week or two after vaccination, you may not yet be fully protected.

How Long Does Protection Last?

Protection from Pneumovax 23 can last for several years, but it's not lifelong. Antibody levels gradually decline over time, which is why certain high-risk groups — including immunocompromised patients and people without a functioning spleen — may be recommended to get a revaccination at least 5 years after the first dose.

For most healthy older adults, a single dose provides meaningful protection. Your doctor can help determine whether you need a second dose based on your specific health situation.

What Makes Pneumovax 23 Different From Other Pneumococcal Vaccines?

There are three main types of pneumococcal vaccines available in the U.S. in 2026, and they work in slightly different ways:

Pneumovax 23 (PPSV23) — Polysaccharide Vaccine

• Covers 23 serotypes — the broadest coverage of any pneumococcal vaccine
• Uses plain polysaccharides (sugar molecules)
• Triggers a T-cell independent response
• Good antibody production but weaker immune memory
• Not effective in children under 2

Prevnar 20 (PCV20) — Conjugate Vaccine

• Covers 20 serotypes
• Uses polysaccharides linked (conjugated) to a carrier protein
• Triggers a T-cell dependent response — creates stronger, longer-lasting immune memory
• Works in children and adults
• May eliminate the need for Pneumovax 23 in some patients when used as a single dose

Vaxneuvance (PCV15) — Conjugate Vaccine

• Covers 15 serotypes
• Also conjugate technology with T-cell dependent response
• When used, it's typically followed by Pneumovax 23 to add coverage for the additional serotypes

Think of it this way: conjugate vaccines like Prevnar 20 are like giving your immune system both a photo and a detailed case file on each criminal. They create deeper, longer-lasting memory. Pneumovax 23 shows more photos (23 vs. 20) but with less detail per photo. Each approach has its strengths.

For a complete comparison, see our guide to Pneumovax 23 alternatives.

Why Pneumovax 23 Still Matters

With newer conjugate vaccines available, you might wonder why Pneumovax 23 is still used. The answer is serotype coverage. Pneumovax 23 covers 23 types of pneumococcal bacteria — 3 more than Prevnar 20 and 8 more than Vaxneuvance. For high-risk patients, those extra serotypes represent real protection against bacteria that could cause serious illness.

That's why current ACIP guidelines recommend the PCV15 + PPSV23 sequence as one option for adult vaccination: you get the stronger immune memory from the conjugate vaccine plus the broader coverage from Pneumovax 23.

Final Thoughts

Pneumovax 23 works by showing your immune system what 23 types of pneumococcal bacteria look like, so your body can build antibodies and fight back if you're ever exposed. It's a straightforward, well-proven approach that's been protecting people for decades. While it doesn't build immune memory as strongly as newer conjugate vaccines, its broad 23-serotype coverage makes it an important part of pneumococcal disease prevention — especially for people at highest risk.

Want to learn more? Read What Is Pneumovax 23? for full details on uses and dosing, or search Medfinder to find it near you.